Hyperbaric Oxygen Treatment is Associated with Lipid Inflammatory Response Assessed Uding Serum Platelet Activating Factor

Open access


Hyperbaric oxygen (HBO) treatment is generally a relatively safe therapy for various conditions. However, there are some adverse side effects. For example HBO tratment has been reported to increase the production of free oxygen radicals(FRs). Furthermore, to our knowledge, no previous clinical research has been carried out to study the involvement of platelet-activating factor(PAF)as the lipid oxidative stressor in patients undergoing HBO treatment. A total of 45 patients included in this study were first given clinical assessment and laboratory measurements before starting HBO treatment and were named group baseline. After the HBO treatment, the same clinical and laboratory measurements from the same patients were repeated and this was named group sesion >20.As expected, long-term HBO treatment had no effect on oxLDL (oxidized low-density lipoprotein), a lipid oxidative stress(OS) marker. However, the mean PAF values in the second group showed a statistically significant increase compared to their pretreatment values, (P <0. 002).As this is a preliminary study, there is a need for more detailed investigations that demonstrate the association of HBO treatment with the lipid inflammatory response. Therefore, there is need for further clinical study for OS markers such as oxLDL in HBO treatment. Clinical prospective studies are required to confirm our laboratory findings.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Sjöberg F Singer M. The medical use of oxygen: a time for critical reappraisal. J Intern Med. 2013 Dec;274(6):505-28. doi: 10.1111/joim.12139;

  • 2. Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci. 2012 Feb 29;8(1):138-53. doi: 10.5114/aoms.2012.27294;

  • 3. Allen MW Golembe E Gorenstein S Butler GJ. Protective effects of hyperbaric oxygen therapy (HBO2) in cardiac care-a proposal to conduct a study into the effects of hyperbaric preconditioning in elective coronary artery bypass graft surgery (CABG). Undersea Hyperb Med.2015 Mar-Apr; 42.107-114. doi:10.2214/ajr.151.5.1003;

  • 4. Davalli P Mitic T Caporali A Lauriola A D’Arca D. ROS cell senescence and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev. 2016;2016:3565127. doi: 10.1155/2016/3565127;

  • 5. Rahal A Kumar A Singh V et al. Oxidative stress prooxidants and antioxidants: the interplay. Biomed Res Int. 2014;2014:761264. doi: 10.1155/2014/761264;

  • 6. Dennog C Hartmann A Frey G Speit G. Detection of DNA damage after hyperbaric oxygen (HBO2) therapy. Mutagenesis. 1996 Nov;11(6):605-609. doi:10.10193;

  • 7. Narkowicz CK Vial JH McCartney PW. Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun. 1993;19(2):71-80. PMID: 8225040 doi:10.3109/10715769309056501;

  • 8. Simsek K Ozler M Ucar E et al. Pressure-related effects of hyperbaric oxygen exposure on oxidation products and antioxidant enzymes in the rat lung. J Exp Integr Med. 2011; 1(1):37-42 doi:10.5455/jeim.130111.or.003;

  • 9. Simsek K Ozler M Yildirim AO et al. Evaluation of the oxidative effect of long term repetitive hyperbaric oxygen exposures on different brain regions of rats. Scientific World Journal. 2012;2012:849183. doi:10.1100/2012/849183;

  • 10. Eren E Ellidag HY Aydin O Yilmaz N. HDL functionality and crystal-based sterile inflammation in atherosclerosis. Clin Chim Acta. 2015 Jan 15;43918-23. doi: 10.1016/j.cca.2014.09.024;

  • 11. McGarry T Biniecka M Veale DJ Fearon U. Hypoxia oxidative stress and inflammation. Free Radic Biol Med. 2018 Mar 27. pii: S0891-5849(18)30145-X. doi: 10.1016/j.freeradbiomed.2018.03.042;

  • 12. Tsoupras A Lordan R Zabetakis I. Inflammation not cholesterol is a cause of chronic disease. Nutrients. 2018 May 12;10(5). pii: E604. doi: 10.3390/nu10050604;

  • 13. Tsoupras AB Iatrou C Frangia C Demopoulos CA. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets. 2009 Aug;9(4):390-9. doi:10.2174/187152609788922555;

  • 14. Palur Ramakrishnan AV Varghese TP Vanapalli S Nair NK Mingate MD. Platelet activating factor: A potential biomarker in acute coronary syndrome? Cardiovasc Ther. 2017 Feb;35(1):64-70. doi: 10.1111/1755-5922.12233;

  • 15. Nakamura T Murata T. Regulation of vascular permeability in anaphylaxis. Br J Pharmacol. 2018 Jul;175(13):2538-2542 doi: 10.1111/bph.14332;

  • 16. Bulger EM Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 2000 Apr;28(4 Suppl):N27-36 doi:10.1097/00003246-200004001-00004;

  • 17. Papakonstantinou VD Lagopati N Tsilibary EC Demopoulos CA Philippopoulos AI. A review on platelet activating factor inhibitors: could a new class of potent metal-based anti-inflammatory drugs induce anticancer properties? Bioinorg Chem Appl. 2017;2017:6947034 doi: 10.1155/2017/6947034;

  • 18. Gao ZX Rao J Li YH. Hyperbaric oxygen preconditioning improves postoperative cognitive dysfunction by reducing oxidant stress and inflammation. Neural Regen Res. 2017 Feb;12(2):329-336 doi: 10.4103/1673-5374.200816;

  • 19. Yildirim G Baştuğ M Akçil IE Fiçicilar H Koç E Zaloğlu N. Does the plateletactivating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. Biol Trace Elem Res. 2000 Winter;78(1-3):7-12. doi:101385/BTER:78:1-3:7;

  • 20. Yildirim G Koç E Baştug M Fiçicilar H Akçil IE Zaloglu N. Effects of plateletactivating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. Undersea Hyperb Med. 2000 Fall;27(3):155-8.doi.org/10.22462/01.02.2018.6;

  • 21. Eren E Yilmaz N Aydin O. High density lipoprotein and it’s dysfunction. Open Biochem J. 2012;6.78-93 doi: 102174/1874091X01206010078;

  • 22. Keskin K Kilci H Aksan G et al. Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy. Turk Kardiyol Dern Ars. 2017 Sep;45(6):533-537. doi: 10.5543/tkda.2017.28302;

  • 23. Matzi V Greilberger JF Lindenmann J et al. Application of hyperbaric oxygen reduce oxidative damage of plasmatic carbonyl proteins and 8-OHdG by activating glutathion peroxidase. Clin Lab. 2015;61(5-6):587-93.doi:10.7754/Clin.Lab.2014.140929;

  • 24. Kudchodkar B Jones H Simecka J Dory L. Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol. 2008 Sep;128(3):435-41. doi: 10.1016/j.clim.2008.05.004; Epub 2008 Jul 2;

  • 25. Kudchodkar BJ Pierce A Dory L. Chronic hyperbaric oxygen treatment elicits an antioxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis. 2007 Jul;193(1):28-35. doi:10.1016/j.atherosclerosis.2006.08.018;

  • 26. Snyder F.Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990 Nov;259 (5 Pt 1):C697-708.doi:10.1152/ajpcell.1990.259.5.C697;

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 74 74 20
PDF Downloads 82 82 14